Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

FASTmC: predictive models for non-reference-based estimations of DNA methylation

ABSTRACT: FASTmC: predictive models for non-reference-based estimations of DNA methylation

PROVIDER: PRJNA293211 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR2171455.fastq.gz	Fastqsanger.gz
	SRR2171456.fastq.gz	Fastqsanger.gz
	SRR2171457.fastq.gz	Fastqsanger.gz
	SRR2171458.fastq.gz	Fastqsanger.gz
	SRR2171459.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

FASTmC: predictive models for non-reference-based estimations of DNA methylation

Project description:We describe a suite of predictive models, coined FASTmC, for non-reference, cost-effective exploration and comparative analysis of context-specific DNA methylation levels. Accurate estimations of true DNA methylation levels can be obtained from as few as several thousand short-reads generated from whole genome bisulfite sequencing. Our models make high-resolution time course or developmental, and large diversity studies practical regardless of species, genome size and availability of a reference genome.

2016-08-17 | GSE72155 | GEO

Comparing Reference-Based RNA-Seq Mapping Methods for Non-Human Primate Data

Project description:We present a comparison of four reference-based mapping methods for mapping non-human primate data to a human reference sequence. We utilize TopHat2 and GSNAP for mapping to the human genome, and Bowtie2 and Stampy for mapping to the human genome and transcriptome for a total of six mapping approaches

2014-07-10 | GSE57485 | GEO

DNA methylation-based classification of sinonasal tumors [reference set]

Project description:DNA methylation-based classification of sinonasal tumors [reference set]

| PRJNA784516 | ENA

Reference Proteome-Based Characterization of Stomach Cancer

Project description:Reference Proteome-Based Stomach Cancer Quantitative Proteome Analysis

2022-07-05 | PXD027082 | JPOST Repository

Production of hiPSC-based tumour models

Project description:Production of hiPSC-based tumour models

| PRJNA777945 | ENA

Comparing Reference-Based RNA-Seq Mapping Methods for Non-Human Primate Data

2014-07-10 | E-GEOD-57485 | biostudies-arrayexpress

Machine Learning Models Predict the Primary Sites of Head and Neck Squamous Cell Carcinoma Metastases Based on DNA Methylation

Project description:In head and neck squamous cell cancers (HNSCs) that present as metastases with an unknown primary (HNSC-CUPs), the identification of a primary tumor improves therapy options and increases patient survival. However, the currently available diagnostic methods are laborious and do not offer a sufficient detection rate. Predictive machine learning models based on DNA methylation profiles have recently emerged as a promising technique for tumor classification. We applied this technique to HNSC to develop a tool that can improve the diagnostic workup for HNSC-CUPs. On a reference cohort of 405 primary HNSC samples, we developed four classifiers based on different machine learning models (random forest (RF), neural network (NN), elastic net penalized logistic regression (LOGREG), support vector machine (SVM)) that predict the primary site of HNSC tumors from their DNA methylation profile. The classifiers achieved high classification accuracies (RF=83%, NN=88%, LOGREG=SVM=89%) on an independent cohort of 64 HNSC metastases. Further, the NN, LOGREG, and SVM models significantly outperformed p16 status as a marker for an origin in the oropharynx. In conclusion, the DNA methylation profiles of HNSC metastases are characteristic for their primary sites and the classifiers developed in this study, which are made available to the scientific community, can provide valuable information to guide the diagnostic workup of HNSC-CUP.

2021-12-08 | GSE171994 | GEO

Enhancing Immunotherapy Outcomes: Spatial Multi-Omics Predictive Models for Non-Small Cell Lung Cancer

Project description:Enhancing Immunotherapy Outcomes: Spatial Multi-Omics Predictive Models for Non-Small Cell Lung Cancer

| PRJNA1132922 | ENA

Peritoneal metastasis of colorectal cancer (pmCRC): Identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models

Project description:14 PDX models of pmCRC were established, including 9 matched PD3D/PDX models, and treatment response to 17 SoC and targeted therapies was monitored, which resulted in drug-dependent inter- and intra-patient specific growth inhibition. Analysis of the molecular data of the models and patient tissue resulted in the identification of predictive biomarkers for treatment with 5-FU, irinotecan, trametinib, erlotinib, cetuximab and avastin, oxaliplatin, selumetinib, docetaxel and everolimus. Conclusions: The establishment of a preclinical drug testing platform based on in vitro and in vivo matched pmCRC models, molecularly characterized by multi-omics technology, facilitated the identification of predictive biomarkers for treatment response, as well as cancer relevant signatures for effective therapies, ready for validation in clinical cohorts.

2022-02-17 | PXD027419 | Pride

Peritoneal metastasis of colorectal cancer (pmCRC): Identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models

2021-10-27 | GSE180790 | GEO